Kalaris Therapeutics Inc

What is Kalaris Therapeutics Inc (KLRS) stock price today?

As of Dec 15, 2025, 8:59 PM UTC, Kalaris Therapeutics Inc (KLRS) stock is trading at $8.47. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date KLRS stock quotes for informed trading decisions.

What is Kalaris Therapeutics Inc's market capitalization?

Kalaris Therapeutics Inc (KLRS) has a market capitalization of approximately $158.4M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Kalaris Therapeutics Inc's size relative to other companies in the USD market. The market cap figure updates automatically as the KLRS stock price changes.

What is the 52-week range for Kalaris Therapeutics Inc stock?

Kalaris Therapeutics Inc (KLRS) stock has traded in a 52-week range of $2.14 — $12.90. The 52-week range shows the highest and lowest prices at which KLRS traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Kalaris Therapeutics Inc stock price to this range provides context for recent price action.

How much trading volume does Kalaris Therapeutics Inc stock have?

Kalaris Therapeutics Inc (KLRS) stock recently traded approximately 88.5K shares. Trading volume indicates market liquidity and investor interest in KLRS. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Kalaris Therapeutics Inc stock.

Does Kalaris Therapeutics Inc pay dividends to shareholders?

Yes, Kalaris Therapeutics Inc (KLRS) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Kalaris Therapeutics Inc stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Kalaris Therapeutics Inc's intraday price range?

Today, Kalaris Therapeutics Inc (KLRS) stock has traded in a range of $8.41 — $8.95. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring KLRS's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Kalaris Therapeutics Inc stock data?

AlphaPilot sources real-time KLRS stock quotes, fundamental financial data, and historical price charts for Kalaris Therapeutics Inc from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Kalaris Therapeutics Inc stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of KLRS stock performance.